Di FioreJMBiomedical engineering aspects of neonatal cardiorespiratory monitoring. In: MartinJRFanaroffAAWalshMC (eds). Fanaroff & Martin’s Neonatal-Perinatal Medicine, 10th ed. Philadelphia: PA: Elsevier Saunders, 2015, pp. 522–535.
2.
NarayenICBlomNAEwerAKet al.Aspects of pulse oximetry screening for critical congenital heart defects: when, how and why. Arch Dis Child Fetal Neonatal Ed2016; 101: F162–67.
3.
BernsteinDEvaluation and screening of the infant or child with congenital heart disease. In: KliegmanRMStantonBFSt GemeJW IIIet al.(eds). Nelson Textbook of Pediatrics, 1st South Asia ed. New Delhi: Elsevier, 2016, pp. 2187–2188.
4.
EwerAKMartinGR. Newborn pulse oximetry screening: which algorithm is best?Pediatrics2016; 138: e20161206–e20161206.
MahleWTNewburgerJWMatherneGPet al.American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Interdisciplinary Council on Quality of Care and Outcomes Research; American Academy of Pediatrics Section on Cardiology And Cardiac Surgery; Committee on Fetus and Newborn. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics2009; 124: 823–836.
7.
EwerAKMiddletonLJFurmstonATet al.for the PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet2011; 378: 785–794.
8.
SaxenaAMehtaARamakrishnanSet al.Pulse oximetry as a screening tool for detecting major congenital heart defects in Indian newborns. Arch Dis Child Fetal Neonatal Ed2015; 100: F416–421.